1805 related articles for article (PubMed ID: 447832)
41. Relation of counterregulatory responses to hypoglycemia in type I diabetics.
Polonsky K; Bergenstal R; Pons G; Schneider M; Jaspan J; Rubenstein A
N Engl J Med; 1982 Oct; 307(18):1106-12. PubMed ID: 7121528
[TBL] [Abstract][Full Text] [Related]
42. Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.
Diamond MP; Hallarman L; Starick-Zych K; Jones TW; Connolly-Howard M; Tamborlane WV; Sherwin RS
J Clin Endocrinol Metab; 1991 Jun; 72(6):1388-90. PubMed ID: 2026760
[TBL] [Abstract][Full Text] [Related]
43. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.
Trümper BG; Reschke K; Molling J
Horm Metab Res; 1995 Mar; 27(3):141-7. PubMed ID: 7607604
[TBL] [Abstract][Full Text] [Related]
44. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
Sherwin RS; Fisher M; Hendler R; Felig P
N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
[TBL] [Abstract][Full Text] [Related]
45. Increase in systolic blood pressure and catecholamine level during hyperinsulinemia in a placebo-controlled euglycemic clamp in healthy subjects.
Kern W; Fittje A; Fohr W; Kerner W; Born J; Fehm HL
Exp Clin Endocrinol Diabetes; 2000; 108(8):498-505. PubMed ID: 11149624
[TBL] [Abstract][Full Text] [Related]
46. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
Wasserman DH; Lickley HL; Vranic M
J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
[TBL] [Abstract][Full Text] [Related]
47. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
Neuhaus C; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
[TBL] [Abstract][Full Text] [Related]
48. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
Davis MR; Mellman M; Shamoon H
Diabetes; 1992 Oct; 41(10):1335-40. PubMed ID: 1397708
[TBL] [Abstract][Full Text] [Related]
49. Evidence against important catecholamine compensation for absent glucagon counterregulation.
De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
[TBL] [Abstract][Full Text] [Related]
50. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects.
Kerr D; MacDonald IA; Tattersall RB
J Clin Endocrinol Metab; 1989 Jun; 68(6):1118-22. PubMed ID: 2656734
[TBL] [Abstract][Full Text] [Related]
51. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
Sacca L; Hendler R; Sherwin RS
J Clin Endocrinol Metab; 1978 Nov; 47(5):1160-3. PubMed ID: 400737
[TBL] [Abstract][Full Text] [Related]
52. Insulin antagonistic effects of epinephrine and glucagon in the dog.
Saccà L; Eigler N; Cryer PE; Sherwin RS
Am J Physiol; 1979 Dec; 237(6):E487-92. PubMed ID: 517645
[TBL] [Abstract][Full Text] [Related]
53. Decreased response of epinephrine and norepinephrine to insulin-induced hypoglycemia in diabetic autonomic neuropathy.
Horie H; Hanafusa T; Matsuyama T; Namba M; Nonaka K; Tarui S; Yamatodani A; Wada H
Horm Metab Res; 1984 Aug; 16(8):398-401. PubMed ID: 6381272
[TBL] [Abstract][Full Text] [Related]
54. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
[TBL] [Abstract][Full Text] [Related]
55. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
Arslanian S; Ohki Y; Becker DJ; Drash AL
Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
[TBL] [Abstract][Full Text] [Related]
56. Alteration of the counterregulatory hormones in the conscious rat after protein-energy restriction.
Leon-Quinto T; Adnot P; Portha B
Diabetologia; 1997 Sep; 40(9):1028-34. PubMed ID: 9300239
[TBL] [Abstract][Full Text] [Related]
57. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
Kerr D; Tamborlane WV; Rife F; Sherwin RS
J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
[TBL] [Abstract][Full Text] [Related]
58. Selective counterregulatory hormone responses after oral glucose in man.
Kleinbaum J; Shamoon H
J Clin Endocrinol Metab; 1982 Oct; 55(4):787-90. PubMed ID: 7107822
[TBL] [Abstract][Full Text] [Related]
59. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?
Bratusch-Marrain P; Vierhapper H; Grubeck-Loebenstein B; Waldhäusl W; Nowotny P
Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914
[TBL] [Abstract][Full Text] [Related]
60. Regulation of glucose homeostasis in humans with denervated livers.
Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
